We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Aillis Stock

Invest in or calculate the value of your shares in Aillis or other pre-IPO companies through EquityZen's platform.

Get Started

Aillis Stock (AILL)

Aillis is an AI-powered medical device for early and accurate influenza detection in the development of innovative medical devices.

About Aillis Stock

Founded

2017

Industries

Software, Artificial Intelligence, Data and Analytics

Aillis specializes in the development of testing methods for Influenza using artificial intelligence technology. The company mainly focuses on new methods of diagnosing influenza. The company was founded in 2017.

Aillis Press Mentions

Stay in the know about the latest news on Aillis

Aillis Management

Leadership team at Aillis

Executive Vice President CSO

Hiroaki Kato

Founder and CEO

Sho Okiyama

Locked Features

Join now and verify your accreditation status to gain access to:

  • Aillis Current Valuation
  • Aillis Stock Price
  • Aillis Management
  • Available deals in Aillis and all other companies with relevant Deal Offering documents
  • EquityZen's proprietary data and insights, which may include
    • Aillis Cap Table and Funding History by Share Class and Liquidity Preferences
    • Aillis Revenue and Financials
    • Aillis Highlights
    • Aillis Business Model
    • Aillis Risk Factors
  • Aillis Research Report from SACRA Research
Join Now

Trading Aillis Stock

How to invest in Aillis stock?

Accredited investors can buy pre-IPO stock in companies like Aillis through EquityZen funds. These investments are made available by existing Aillis shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Aillis stock?

Shareholders can sell their Aillis stock through EquityZen's private company marketplace. EquityZen's network includes over 380K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."